Floxuridine

Catalog No.S1299 Synonyms: Deoxyfluorouridine, FDUR, NSC 27640

Floxuridine Chemical Structure

Molecular Weight(MW): 246.19

Floxuridine is an antineoplastic antimetabolite, used in the treatment of colon carcinoma and colorectal cancer that has metastasized to the liver.

Size Price Stock Quantity  
USD 97 In stock
USD 297 In stock
Bulk Discount

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

Purity & Quality Control

Choose Selective DNA/RNA Synthesis Inhibitors

Biological Activity

Description Floxuridine is an antineoplastic antimetabolite, used in the treatment of colon carcinoma and colorectal cancer that has metastasized to the liver.
In vitro

Floxuridine exhibits higher affinity for PEPT1 than the corresponding 5'-O-mono amino acid ester prodrugs. [1] Floxuridine combined with Leucovorin results in synergistic inhibitory effects on growth of human T-lymphoblast leukemia cells. [2] Floxuridine significantly inhibits the uptake of both [(3)H]-inosine and [(3)H]-adenosine (60-70% of control), while its amino acid ester prodrugs including Val, Phe, Pro, Asp, and Lys esters exhibits markedly decreased inhibition potency (10-30% of control). [3] Floxuridine inhibits cell proliferation by more than 50% relative to the untreated control cells at 36 days, the cell numbers still increases fourfold compared with the initial cell density. Floxuridine results in prolonged effects on the proliferation of human Tenon's capsule fibroblasts in vitro. [4] Floxuridine (FUDR) is an ideal drug for hepatic arterial infusion (HAI) due to its short half life, steep dose response curve, high total body clearance, and high hepatic extraction. [5]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
CCRF-CEM cell NEi2UG9Iem:5dHigbY5pcWKrdHnvckBie3OjeR?= MnP1WIV{fGWmIHnuJJZqfHKxIH\vdkB1cGViaX7obYJqfGmxbjDv[kBk\WyuIHfyc5d1cCCxZjDoeY1idiCWIHz5cZBpd2KuYYP0c4llKEOFUl[tR2VOKGOnbHygcIlv\SBqQWTDR{BES0xiMUG5LUwhUUN3ME2wMlUh|ryP NGDH[2cyOTlyOUexOi=>
CCRF-CEM NFXwd49Iem:5dHigbY5pcWKrdHnvckBie3OjeR?= MUHJckB3cXS{bzDjc45k\W62cnH0bY9vKHKncYXpdoVlKG[xcjC1NEUhcW6qaXLpeIlwdiCxZjDndo94fGhib3[gbJVu[W5ibHX1b4VucWFiY3XscEBtcW6nIFPDVmYuS0WPIIfpeIghcFCDUDCoNE4zKHWwaYSvcWwqNCCJSUWwQVAvODByNjFOwG0> NWrx[5NCOTF3OUe0NFQ>
LNCaP cells MVTDfZRwfG:6aXPpeJkh[XO|YYm= NInMWYREgXSxdH;4bYMh[2:wY3XueJJifGmxbjDpckBxem:|dHH0[UB{eGWlaX\pZ{BidnSrZ3XuJEhRW0FrIIDyc4R2[2mwZzDoeY1idiCOTlPhVEBk\WyuczygTWM2OD1yLkC2PVIh|ryP M3fnNFEzOTZzMUW3
TSU cells M{TYeWN6fG:2b4jpZ4l1gSCjc4PhfS=> NXuwPIp2S3m2b4TvfIlkKGOxbnPlcpRz[XSrb36gbY4hdm:wIIDyc5N1[XSnIIPw[YNq\mmlIHHueIlo\W5iKGDTRUkheHKxZIXjbY5oKGi3bXHuJHRUXSClZXzsd{whUUN3ME2wMlA2QCEQvF2= NVjreYJOOTJzNkGxOVc>
KBALB cell MoKwR5l1d3SxeHnjbZR6KGG|c3H5 MUfJckB3cXS{bzDj[YxtKGO7dH;0c5hq[2m2eTDh[4FqdnO2IFvCRWxDKGOnbHygcIlv\SBqdILhcpNnd3KvZXSg[oljem:kbHHzeEB{[XKlb33hJINmdGxibHnu[UktKEOFNUC9Ok4xOEVvMEWg{txO MUSxNlYzODB5Nh?=
KBALB-STK cell NGHyfotEgXSxdH;4bYNqfHliYYPzZZk> MorlTY4hfmm2cn:gZ4VtdCCleYTveI95cWOrdImgZYdicW6|dDDLRmFNSi2VVFugZ4VtdCCuaX7ld{BmgHC{ZYPz[YQhcW5iSGPWMVEhXEtuIFnDOVA:QC56MFWtNFUh|ryP MVexNlYzODB5Nh?=
L1210 mouse leukemia cells NXXLc4cyT3Kxd4ToJIlvcGmkaYTpc44h[XO|YYm= M4XUb|I1KGh? MWDHdo94fGhiaX7obYJqfGmxbjDpckBNOTJzMDDtc5V{\SCuZYXr[Y1q[SClZXzsd{Bi\nSncjCyOEBpKHS{ZXH0cYVvfCxiSVO1NF0xNjByNEGg{txO NH\xbo8yOTd{OEG5Ny=>
L1210 mouse leukemia cells NIW0dGpIem:5dHigbY5pcWKrdHnvckBie3OjeR?= M3jvVVQ5KGh? M1TVU2dzd3e2aDDpcohq[mm2aX;uJIlvKExzMkGwJI1wfXOnIHzleYtmdWmjIHPlcIx{KGGodHXyJFQ5KGi{IITy[YF1dWWwdDygTWM2OD1yLkCwNFY1KM7:TR?= NHjlcVAyOTd{OEG5Ny=>
L5178Y cell MnfRS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl? MlTyR49ueGG{YYTpeoUhcW6qaXLpeIlwdiCxZjDMOVE4QFliY3XscEBoem:5dHigbY4hfmm2cn:gLINwdmOnboTyZZRqd25icnXxeYlz\WRiZn;yJFUxLSCrbnjpZol1cW:wKTygTWM2OD1yLkCwNFc3KM7:TR?= NEnCV3Q3Pzd7MEC3
L5178Y cells NXPpUnhXTnWwY4Tpc44h[XO|YYm= NEjxRZFKdmirYnn0c5J6KGOxbnPlcpRz[XSrb36gc4Yh[2:vcH;1coQhf2G|IHPhcIN2dGG2ZXSgc44hVDVzN{jZJINmdGy|IHL5JHsyPEOfTHX1JIlv[2:{cH;yZZRqd25uIFnDOVA:OiEQvF2= MlHEPFI1PjJ{OR?=
L1210 mouse leukemia cells MkLMSpVv[3Srb36gZZN{[Xl? NIHVTWQzKGh? NGfwWopVcHmvaXT5cIF1\SC|eX70bIF{\SCrbnjpZol1cW:wIHnuJGwyOjFyIH3veZNmKGyndXvlcYliKGOnbHzzJIFnfGW{IEKgbJIhfHKnYYTt[Y51NCCLQ{WwQVAvODB5OTFOwG0> NYfON5R1OTF5MkixPVM>
LM cells NIXEe21HfW6ldHnvckBie3OjeR?= NX7ZZ|B[OiCq NV\6XXI4XGi7bXnkfYxifGVic4nueIhie2ViaX7obYJqfGmxbjDpckB1cHmvaXTpcoUhc2mwYYPlJIRm\mmlaXXueEBNVSClZXzsd{Bi\nSncjCyJIhzKHS{ZXH0cYVvfCxiSVO1NF02NjRizszN NHnrVYsyOTd{OEG5Ny=>
HT1080 cells M2m2W2Z2dmO2aX;uJIF{e2G7 M{XLZmN6fG:|dHH0bYMh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDIWFExQDBiY3XscJMh[nliTWTUJIF{e2G7LDDJR|UxRTBwMUig{txO NH30eHUyPzhyNEKzNS=>
L1210 cells NX\NPId7T3Kxd4ToJIlvcGmkaYTpc44h[XO|YYm= MlnnO|IhcA>? MYLDfZRwe3SjdHnjJIFkfGm4aYT5JIFo[Wmwc4SgcY92e2ViTEGyNVAh[2WubIOgRXRESyCFQ1yyNVkh[XO|ZYPz[YQh[XNiZ4Lve5RpKHKnZIXjeIlwdiCjZoTldkA4OiCqcoOsJGlEPTB;MD6wNVIh|ryP Mn7MNVc6QTd|MUm=
HL60 cells M1zDeWdzd3e2aDDpcohq[mm2aX;uJIF{e2G7 NWLQXZF4PzJiaB?= MoPrR5l1d3O2YYTpZ{Bi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFjMOlAh[2WubIOgRXRESyCFQ1ygNlQxKGG|c3Xzd4VlKGG|IHfyc5d1cCC{ZXT1Z5Rqd25iYX\0[ZIhPzJiaILzMEBKSzVyPUCuNFEzKM7:TR?= Mn63NVc6QTd|MUm=
CCRF-CEM cells NF72OmdIem:5dHigbY5pcWKrdHnvckBie3OjeR?= MkXsO|IhcA>? MlzOR5l1d3O2YYTpZ{Bi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFPDVmYuS0WPIHPlcIx{KEGWQ1OgR2NNKDFzOTDhd5Nme3OnZDDhd{Boem:5dHigdoVlfWO2aX;uJIFnfGW{IEeyJIhzeyxiSVO1NF0xNjBzNzFOwG0> NILGfGgyPzl7N{OxPS=>
L1210 cells NEDtUWxIem:5dHigbY5pcWKrdHnvckBie3OjeR?= MoXzO|IhcA>? NUPSdYhGS3m2b4P0ZZRq[yCjY4Tpeol1gSCrbjDtc5V{\SCOMUKxNEBk\WyuczDhd5Nme3OnZDDhd{BqdmirYnn0bY9vKG:oIHPlcIwh\3Kxd4ToJIFnfGW{IEeyJIhzeyxiSVO1NF0xNjBzMjFOwG0> MYixPFA4QDd3Nx?=
HL60 cells NIfG[3VIem:5dHigbY5pcWKrdHnvckBie3OjeR?= M1jtSFczKGh? Mmr6R5l1d3O2YYTpZ{Bi[3Srdnn0fUBqdiCqdX3hckBJVDZyIHPlcIx{KGG|c3Xzd4VlKGG|IHnubIljcXSrb36gc4Yh[2WubDDndo94fGhiYX\0[ZIhPzJiaILzMEBKSzVyPUCuNFEzKM7:TR?= Ml\uNVgxPzh5NUe=
CCRF-CEM cells NFyxW29Iem:5dHigbY5pcWKrdHnvckBie3OjeR?= MWm3NkBp NWXT[2FDS3m2b4P0ZZRq[yCjY4Tpeol1gSCrbjDoeY1idiCFQ2LGMWNGVSClZXzsd{Bie3Onc4Pl[EBieyCrbnjpZol1cW:wIH;mJINmdGxiZ4Lve5RpKGGodHXyJFczKGi{czygTWM2OD1yLkCxO{DPxE1? NH3wXWMyQDB5OEe1Oy=>
CCRF-CEM cells MkH6SpVv[3Srb36gZZN{[Xl? MnO2OFghcA>? NYKyOodISW62aXPhcoNmeiCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJGNEWkZvQ1XNJINmdGy|IHHmeIVzKDR6IHjyd{BjgSC|dXzmc5Jpd2SjbXnu[UBDKGG|c3H5MEBIUTVyPUCuNFA3OzFizszN MkjXNVk4PDR6NUi=
K562 cells NWPMOpZ1TnWwY4Tpc44h[XO|YYm= NIfkfHU1QCCq Mm[wRY51cWOjbnPldkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFu1OlIh[2WubIOgZYZ1\XJiNEigbJJ{KGK7IIP1cIZwemixZHHtbY5mKEJiYYPzZZktKEeLNUC9NE44QTR|MzFOwG0> MUixPVc1PDh3OB?=
MOLT4 cells M3nnXGZ2dmO2aX;uJIF{e2G7 NGPoPJA1QCCq NH7IdFRCdnSrY3HuZ4VzKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gUW9NXDRiY3XscJMh[W[2ZYKgOFghcHK|IHL5JJN2dG[xcnjv[IFucW6nIFKgZZN{[XluIFfJOVA:OC5yM{m4NUDPxE1? NVT2cXI2OTl5NES4OVg>
RPMI8266 cells NFrsdoRHfW6ldHnvckBie3OjeR?= NG\wcmE1QCCq MlXGRY51cWOjbnPldkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIGLQUWk5OjZ4IHPlcIx{KGGodHXyJFQ5KGi{czDifUB{fWyob4Loc4RidWmwZTDCJIF{e2G7LDDHTVUxRTBwN{m0N|Mh|ryP MVGxPVc1PDh3OB?=
human SR cells M{\KNGZ2dmO2aX;uJIF{e2G7 MkPxOFghcA>? MonZRY51cWOjbnPldkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIGPSJINmdGy|IHHmeIVzKDR6IHjyd{BjgSC|dXzmc5Jpd2SjbXnu[UBDKGG|c3H5MEBIUTVyPUCuNFEzPTlizszN Mm[1NVk4PDR6NUi=
A549 cells Ml7jSpVv[3Srb36gZZN{[Xl? M4\aO|Q5KGh? NUP3TXY6SW62aXPhcoNmeiCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJGE2PDliY3XscJMh[W[2ZYKgOFghcHK|IHL5JJN2dG[xcnjv[IFucW6nIFKgZZN{[XluIFfJOVA:OC5yMUK1PUDPxE1? M3r5WFE6PzR2OEW4
EKVX cells NFvUVHNHfW6ldHnvckBie3OjeR?= M4TI[FQ5KGh? NFrHXYpCdnSrY3HuZ4VzKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gSWtXYCClZXzsd{Bi\nSncjC0PEBpenNiYomgd5Vt\m:{aH;kZY1qdmViQjDhd5NigSxiR1m1NF0yOCEQvF2= M{fGZlE6PzR2OEW4
HOP62 cells MUnGeY5kfGmxbjDhd5NigQ>? Ml62OFghcA>? MXHBcpRq[2GwY3XyJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iSF;QOlIh[2WubIOgZYZ1\XJiNEigbJJ{KGK7IIP1cIZwemixZHHtbY5mKEJiYYPzZZktKEeLNUC9NE4xOjVzMjFOwG0> MlW3NVk4PDR6NUi=
HOP92 cells Mo\QSpVv[3Srb36gZZN{[Xl? NYXLeFdKPDhiaB?= NXvyOnVNSW62aXPhcoNmeiCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJGhQWDl{IHPlcIx{KGGodHXyJFQ5KGi{czDifUB{fWyob4Loc4RidWmwZTDCJIF{e2G7LDDHTVUxRTBwN{m0N|Mh|ryP MUKxPVc1PDh3OB?=
NCI-H226 cells MnqySpVv[3Srb36gZZN{[Xl? NWXxV3VlPDhiaB?= MWHBcpRq[2GwY3XyJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iTlPJMWgzOjZiY3XscJMh[W[2ZYKgOFghcHK|IHL5JJN2dG[xcnjv[IFucW6nIFKgZZN{[Xl? NXTneY9nOTl5NES4OVg>
NCI-H23 Mnn2SpVv[3Srb36gZZN{[Xl? MlXUOFghcA>? NXW5c2ZKSW62aXPhcoNmeiCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJG5EUS2KMkOgZ4VtdHNiYX\0[ZIhPDhiaILzJIJ6KHO3bH\vdohw\GGvaX7lJGIh[XO|YYmsJGdKPTB;MUCg{txO MlfXNVk4PDR6NUi=
NCI-H322 MYDGeY5kfGmxbjDhd5NigQ>? NIKzTXc1QCCq M2\qcmFvfGmlYX7j[ZIh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDOR2kuUDN{Ml2gZ4VtdHNiYX\0[ZIhPDhiaILzJIJ6KHO3bH\vdohw\GGvaX7lJGIh[XO|YYmsJGdKPTB;MD61NFEyQSEQvF2= M2C5fVE6PzR2OEW4
NCI-H460 NED3fIlHfW6ldHnvckBie3OjeR?= NUDMbmpOPDhiaB?= MlvsRY51cWOjbnPldkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIF7DTU1JPDZyIHPlcIx{KGGodHXyJFQ5KGi{czDifUB{fWyob4Loc4RidWmwZTDCJIF{e2G7LDDHTVUxRTBwNUCxNVkh|ryP Mkn6NVk4PDR6NUi=
NCI-H522 MYPGeY5kfGmxbjDhd5NigQ>? NEP1SFM1QCCq MoHVRY51cWOjbnPldkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIF7DTU1JPTJ{IHPlcIx{KGGodHXyJFQ5KGi{czDifUB{fWyob4Loc4RidWmwZTDCJIF{e2G7LDDHTVUxRTBwMECyJO69VQ>? MojaNVk4PDR6NUi=
COLO205 cells NXXiZpNkTnWwY4Tpc44h[XO|YYm= M17OXVQ5KGh? NIDlT2VCdnSrY3HuZ4VzKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gR29NVzJyNTDj[YxteyCjZoTldkA1QCCqcoOgZpkhe3WuZn;ybI9l[W2rbnWgRkBie3OjeTygS2k2OD1{LkWxNVg6KM7:TR?= NYnGU41ZOTl5NES4OVg>
HCC2998 cells Ml3YSpVv[3Srb36gZZN{[Xl? M3P4OVQ5KGh? NXna[phnSW62aXPhcoNmeiCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJGhESzJ7OUigZ4VtdHNiYX\0[ZIhPDhiaILzJIJ6KHO3bH\vdohw\GGvaX7lJGIh[XO|YYmsJGdKPTB;MT61PFQ5QSEQvF2= M13hTVE6PzR2OEW4
HCT116 cells MWfGeY5kfGmxbjDhd5NigQ>? M2TiVVQ5KGh? MnjiRY51cWOjbnPldkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFjDWFEyPiClZXzsd{Bi\nSncjC0PEBpenNiYomgd5Vt\m:{aH;kZY1qdmViQjDhd5NigSxiR1m1NF0xNjByMTFOwG0> M3HaOVE6PzR2OEW4
HCT15 cells M2HoTGZ2dmO2aX;uJIF{e2G7 NYT3c4V4PDhiaB?= MkjaRY51cWOjbnPldkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFjDWFE2KGOnbHzzJIFnfGW{IES4JIhzeyCkeTDzeYxnd3Kqb3ThcYlv\SCEIHHzd4F6NCCJSUWwQVAvOTJ3OEmg{txO NH7CTY4yQTd2NEi1PC=>
HT-29 cells MWnGeY5kfGmxbjDhd5NigQ>? M2\IXVQ5KGh? NH7PNVhCdnSrY3HuZ4VzKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gTHQuOjliY3XscJMh[W[2ZYKgOFghcHK|IHL5JJN2dG[xcnjv[IFucW6nIFKgZZN{[XluIFfJOVA:OS57OUWyOkDPxE1? MYSxPVc1PDh3OB?=
KM12 cells M1jae2Z2dmO2aX;uJIF{e2G7 NGS0bo81QCCq MYjBcpRq[2GwY3XyJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iS12xNkBk\WyuczDh[pRmeiB2ODDodpMh[nlic4Xs[o9zcG:mYX3pcoUhSiCjc4PhfUwhT0l3ME2yMlUyOTh7IN88US=> MlTHNVk4PDR6NUi=
SW620 cells NIf4e4tHfW6ldHnvckBie3OjeR?= NFrYUIg1QCCq NHezbopCdnSrY3HuZ4VzKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gV3c3OjBiY3XscJMh[W[2ZYKgOFghcHK|IHL5JJN2dG[xcnjv[IFucW6nIFKgZZN{[XluIFfJOVA:Pi5|MEm1O{DPxE1? M2POOFE6PzR2OEW4
SF268 cells NIHoNIFHfW6ldHnvckBie3OjeR?= NWT4UG04PDhiaB?= NX3Mbo9wSW62aXPhcoNmeiCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJHNHOjZ6IHPlcIx{KGGodHXyJFQ5KGi{czDifUB{fWyob4Loc4RidWmwZTDCJIF{e2G7LDDHTVUxRTFyIN88US=> NEHoV2YyQTd2NEi1PC=>
SF295 cells Mle0SpVv[3Srb36gZZN{[Xl? NXu5THlpPDhiaB?= M{HmNWFvfGmlYX7j[ZIh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDTSlI6PSClZXzsd{Bi\nSncjC0PEBpenNiYomgd5Vt\m:{aH;kZY1qdmViQjDhd5NigSxiR1m1NF0xNjBzMkW5JO69VQ>? M2rZRVE6PzR2OEW4
SF539 cells M3zGWmZ2dmO2aX;uJIF{e2G7 MnPWOFghcA>? M3H2eGFvfGmlYX7j[ZIh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDTSlU{QSClZXzsd{Bi\nSncjC0PEBpenNiYomgd5Vt\m:{aH;kZY1qdmViQjDhd5NigSxiR1m1NF0xNjB|OUixJO69VQ>? MXexPVc1PDh3OB?=
SNB19 cells Mle5SpVv[3Srb36gZZN{[Xl? MXS0PEBp NGfIUIdCdnSrY3HuZ4VzKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gV25DOTliY3XscJMh[W[2ZYKgOFghcHK|IHL5JJN2dG[xcnjv[IFucW6nIFKgZZN{[XluIFfJOVA:OS57OUWyOkDPxE1? NWnKOWlXOTl5NES4OVg>
SNB75 cells NHnmRmZHfW6ldHnvckBie3OjeR?= NXHZfWtOPDhiaB?= NI[xPFVCdnSrY3HuZ4VzKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gV25DPzViY3XscJMh[W[2ZYKgOFghcHK|IHL5JJN2dG[xcnjv[IFucW6nIFKgZZN{[XluIFfJOVA:OC5zOUm1N{DPxE1? MYCxPVc1PDh3OB?=
U251 cells NEHKWGZHfW6ldHnvckBie3OjeR?= MYG0PEBp M1fueGFvfGmlYX7j[ZIh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDVNlUyKGOnbHzzJIFnfGW{IES4JIhzeyCkeTDzeYxnd3Kqb3ThcYlv\SCEIHHzd4F6NCCJSUWwQVAvOTJ3OEmg{txO NUTU[IdDOTl5NES4OVg>
LOXIMVI cells MXzGeY5kfGmxbjDhd5NigQ>? M2TENVQ5KGh? NWnLUWtWSW62aXPhcoNmeiCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJGxQYEmPVlmgZ4VtdHNiYX\0[ZIhPDhiaILzJIJ6KHO3bH\vdohw\GGvaX7lJGIh[XO|YYmsJGdKPTB;MD6wNlUyOiEQvF2= NFvKeXcyQTd2NEi1PC=>
MALME-3M cells NELEbG9HfW6ldHnvckBie3OjeR?= M3jm[|Q5KGh? MkfWRY51cWOjbnPldkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIF3BUG1GNTOPIHPlcIx{KGGodHXyJFQ5KGi{czDifUB{fWyob4Loc4RidWmwZTDCJIF{e2G7LDDHTVUxRTdwOUSzNlgh|ryP MVOxPVc1PDh3OB?=
M14 cells NVn3fYVmTnWwY4Tpc44h[XO|YYm= NFOxVpY1QCCq MUTBcpRq[2GwY3XyJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iTUG0JINmdGy|IHHmeIVzKDR6IHjyd{BjgSC|dXzmc5Jpd2SjbXnu[UBDKGG|c3H5MEBIUTVyPUCuNVU5PDlizszN MX[xPVc1PDh3OB?=
SK-MEL-2 cells NIG4ZXBHfW6ldHnvckBie3OjeR?= M1zZe|Q5KGh? MmjFRY51cWOjbnPldkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIGPLMW1GVC1{IHPlcIx{KGGodHXyJFQ5KGi{czDifUB{fWyob4Loc4RidWmwZTDCJIF{e2G7LDDHTVUxRTFyIN88US=> MoPsNVk4PDR6NUi=
SK-MEL-28 cells NUHQdXRHTnWwY4Tpc44h[XO|YYm= MlXXOFghcA>? MV7BcpRq[2GwY3XyJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iU1utUWVNNTJ6IHPlcIx{KGGodHXyJFQ5KGi{czDifUB{fWyob4Loc4RidWmwZTDCJIF{e2G7LDDHTVUxRTFwOUm1NlYh|ryP NXL6NGN7OTl5NES4OVg>
SK-MEL-5 cells MkHvSpVv[3Srb36gZZN{[Xl? NIPTWG41QCCq NWjpclhxSW62aXPhcoNmeiCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJHNMNU2HTD21JINmdGy|IHHmeIVzKDR6IHjyd{BjgSC|dXzmc5Jpd2SjbXnu[UBDKGG|c3H5MEBIUTVyPUCuNVk6PTNizszN NYnJdVlXOTl5NES4OVg>
UACC257 cells MYDGeY5kfGmxbjDhd5NigQ>? MYm0PEBp MV7BcpRq[2GwY3XyJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iVVHDR|I2PyClZXzsd{Bi\nSncjC0PEBpenNiYomgd5Vt\m:{aH;kZY1qdmViQjDhd5NigSxiR1m1NF0{NjF4MkK4JO69VQ>? NFrpXlQyQTd2NEi1PC=>
UACC62 cells MoXQSpVv[3Srb36gZZN{[Xl? NIey[pg1QCCq NHTLOZBCdnSrY3HuZ4VzKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gWWFESzZ{IHPlcIx{KGGodHXyJFQ5KGi{czDifUB{fWyob4Loc4RidWmwZTDCJIF{e2G7LDDHTVUxRTBwMEO5PFEh|ryP NVfMNoh6OTl5NES4OVg>
IGROV1 cells NVPIWVN6TnWwY4Tpc44h[XO|YYm= MmTtOFghcA>? MXjBcpRq[2GwY3XyJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iSVfSU3YyKGOnbHzzJIFnfGW{IES4JIhzeyCkeTDzeYxnd3Kqb3ThcYlv\SCEIHHzd4F6NCCJSUWwQVIvPTFzOEmg{txO MVGxPVc1PDh3OB?=
OVCAR-3 cells MVvGeY5kfGmxbjDhd5NigQ>? M3XOdVQ5KGh? M13pfWFvfGmlYX7j[ZIh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDPWmNCWi1|IHPlcIx{KGGodHXyJFQ5KGi{czDifUB{fWyob4Loc4RidWmwZTDCJIF{e2G7LDDHTVUxRTJwNUGxPFkh|ryP NVL4N3p1OTl5NES4OVg>
OVCAR4 cells NVjFXJdnTnWwY4Tpc44h[XO|YYm= NUPjc4dKPDhiaB?= M3PERWFvfGmlYX7j[ZIh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDPWmNCWjRiY3XscJMh[W[2ZYKgOFghcHK|IHL5JJN2dG[xcnjv[IFucW6nIFKgZZN{[XluIFfJOVA:OTBizszN MkDnNVk4PDR6NUi=
OVCAR5 cells M{LEW2Z2dmO2aX;uJIF{e2G7 MlW1OFghcA>? MVTBcpRq[2GwY3XyJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iT2\DRXI2KGOnbHzzJIFnfGW{IES4JIhzeyCkeTDzeYxnd3Kqb3ThcYlv\SCEIHHzd4F6NCCJSUWwQVYvOzB7NUeg{rxu MorlNVk4PDR6NUi=
OVCAR8 cells NELMVFdHfW6ldHnvckBie3OjeR?= NGPwUWk1QCCq MXvBcpRq[2GwY3XyJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iT2\DRXI5KGOnbHzzJIFnfGW{IES4JIhzeyCkeTDzeYxnd3Kqb3ThcYlv\SCEIHHzd4F6NCCJSUWwQVAvOTJ3OEmg{txO NHS5e3gyQTd2NEi1PC=>
SKOV3 cells M2TDNmZ2dmO2aX;uJIF{e2G7 MmP4OFghcA>? NFmzOVJCdnSrY3HuZ4VzKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gV2tQXjNiY3XscJMh[W[2ZYKgOFghcHK|IHL5JJN2dG[xcnjv[IFucW6nIFKgZZN{[XluIFfJOVA:OS57OUWyOkDPxE1? MkHJNVk4PDR6NUi=
786-0 cells MkPLSpVv[3Srb36gZZN{[Xl? NUOyVJVvPDhiaB?= MlHwRY51cWOjbnPldkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIEe4Ok0xKGOnbHzzJIFnfGW{IES4JIhzeyCkeTDzeYxnd3Kqb3ThcYlv\SCEIHHzd4F6NCCJSUWwQVAvOSEQvF2= M1\5R|E6PzR2OEW4
A498 cells NVLMXJpOTnWwY4Tpc44h[XO|YYm= MUK0PEBp MXzBcpRq[2GwY3XyJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iQUS5PEBk\WyuczDh[pRmeiB2ODDodpMh[nlic4Xs[o9zcG:mYX3pcoUhSiCjc4PhfUwhT0l3ME2xMlI2QDl|IN88US=> M1jOSFE6PzR2OEW4
ACHN cells MXTGeY5kfGmxbjDhd5NigQ>? MV20PEBp MmPjRY51cWOjbnPldkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFHDTG4h[2WubIOgZYZ1\XJiNEigbJJ{KGK7IIP1cIZwemixZHHtbY5mKEJiYYPzZZktKEeLNUC9NE4xOzF4MjFOwG0> M1TIWFE6PzR2OEW4
Caki1 cells MkK3SpVv[3Srb36gZZN{[Xl? NWnJc2lUPDhiaB?= NGrwXmNCdnSrY3HuZ4VzKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gR4FscTFiY3XscJMh[W[2ZYKgOFghcHK|IHL5JJN2dG[xcnjv[IFucW6nIFKgZZN{[XluIFfJOVA:OC5yM{G2NkDPxE1? NYrRV|REOTl5NES4OVg>
SN12C cells NWPzcmgyTnWwY4Tpc44h[XO|YYm= MoH2OFghcA>? MXPBcpRq[2GwY3XyJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iU16xNmMh[2WubIOgZYZ1\XJiNEigbJJ{KGK7IIP1cIZwemixZHHtbY5mKEJiYYPzZZktKEeLNUC9NE4yQTl3MzFOwG0> MYixPVc1PDh3OB?=
TK10 cells MXnGeY5kfGmxbjDhd5NigQ>? M2LZT|Q5KGh? NE\JPHRCdnSrY3HuZ4VzKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gWGsyOCClZXzsd{Bi\nSncjC0PEBpenNiYomgd5Vt\m:{aH;kZY1qdmViQjDhd5NigSxiR1m1NF02NjBzMUi3JO69VQ>? NFrCW3gyQTd2NEi1PC=>
UO31 cells MoXsSpVv[3Srb36gZZN{[Xl? NIX0[3Y1QCCq MoO1RY51cWOjbnPldkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIGXPN|Eh[2WubIOgZYZ1\XJiNEigbJJ{KGK7IIP1cIZwemixZHHtbY5mKEJiYYPzZZktKEeLNUC9NE4yOjV6OTFOwG0> NVTSRYFkOTl5NES4OVg>
PC3 cells NGDhWXRHfW6ldHnvckBie3OjeR?= NYXvXGZKPDhiaB?= MmX5RY51cWOjbnPldkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIGDDN{Bk\WyuczDh[pRmeiB2ODDodpMh[nlic4Xs[o9zcG:mYX3pcoUhSiCjc4PhfUwhT0l3ME2wMlMyPjJ|IN88US=> MUOxPVc1PDh3OB?=
DU145 cells NEWxZlVHfW6ldHnvckBie3OjeR?= MmDYOFghcA>? M{fROWFvfGmlYX7j[ZIh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDEWVE1PSClZXzsd{Bi\nSncjC0PEBpenNiYomgd5Vt\m:{aH;kZY1qdmViQjDhd5NigSxiR1m1NF0xNjJ3MUG5JO69VQ>? MoC2NVk4PDR6NUi=
MCF7 cells MlTPSpVv[3Srb36gZZN{[Xl? MYK0PEBp MojIRY51cWOjbnPldkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIF3DSlch[2WubIOgZYZ1\XJiNEigbJJ{KGK7IIP1cIZwemixZHHtbY5mKEJiYYPzZZktKEeLNUC9NE4xODZ|MTFOwG0> M{HSSVE6PzR2OEW4
NCI/ADR-RES cells NH3NZ3hHfW6ldHnvckBie3OjeR?= MkjOOFghcA>? NYjGUGNmSW62aXPhcoNmeiCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJG5EUS:DRGKtVmVUKGOnbHzzJIFnfGW{IES4JIhzeyCkeTDzeYxnd3Kqb3ThcYlv\SCEIHHzd4F6NCCJSUWwQVEvOjV6OUOg{txO MmnoNVk4PDR6NUi=
MDA-MB-231 cells NEL0N3NHfW6ldHnvckBie3OjeR?= NH3tfGY1QCCq M2i3fmFvfGmlYX7j[ZIh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDNSGEuVUJvMkOxJINmdGy|IHHmeIVzKDR6IHjyd{BjgSC|dXzmc5Jpd2SjbXnu[UBDKGG|c3H5MEBIUTVyPUOuPVgyODdizszN MWWxPVc1PDh3OB?=
Hs 578T cells NViyTIp3TnWwY4Tpc44h[XO|YYm= MXq0PEBp NFP0flJCdnSrY3HuZ4VzKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gTJMhPTd6VDDj[YxteyCjZoTldkA1QCCqcoOgZpkhe3WuZn;ybI9l[W2rbnWgRkBie3OjeTygS2k2OD1|Lkm4NVA4KM7:TR?= MXOxPVc1PDh3OB?=
MDA-MB-435 cells M1\OdGZ2dmO2aX;uJIF{e2G7 NHvu[HI1QCCq MmHDRY51cWOjbnPldkBi[3Srdnn0fUBi\2GrboP0JIh2dWGwIF3ERU1OSi12M{WgZ4VtdHNiYX\0[ZIhPDhiaILzJIJ6KHO3bH\vdohw\GGvaX7lJGIh[XO|YYmsJGdKPTB;Mz6xOlIzQCEQvF2= MlvONVk4PDR6NUi=
MDA-N cells M{HlW2Z2dmO2aX;uJIF{e2G7 MYC0PEBp M3vVRmFvfGmlYX7j[ZIh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDNSGEuViClZXzsd{Bi\nSncjC0PEBpenNiYomgd5Vt\m:{aH;kZY1qdmViQjDhd5NigSxiR1m1NF0yNjJ3OEmzJO69VQ>? NFvYfWsyQTd2NEi1PC=>
BT549 cells M{XoXWZ2dmO2aX;uJIF{e2G7 NHHwfIM1QCCq M3vaVmFvfGmlYX7j[ZIh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDCWFU1QSClZXzsd{Bi\nSncjC0PEBpenNiYomgd5Vt\m:{aH;kZY1qdmViQjDhd5NigSxiR1m1NF0yKM7:TR?= MXWxPVc1PDh3OB?=
T47D cells M4rt[GZ2dmO2aX;uJIF{e2G7 MojLOFghcA>? MWHBcpRq[2GwY3XyJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iVES3SEBk\WyuczDh[pRmeiB2ODDodpMh[nlic4Xs[o9zcG:mYX3pcoUhSiCjc4PhfUwhT0l3ME2xMlI2QDl|IN88US=> NF3td3IyQTd2NEi1PC=>
HepG2 cells NHHXS4VEgXSxdH;4bYNqfHliYYPzZZk> MlvUO|IhcA>? M3n0fWN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGhmeEd{IHPlcIx{KGGodHXyJFczKGi{czDifUBOXFRiYYPzZZktKEWFNUC9NVgvQDRizszN Mkf5NVk6OTd3Mki=
A549 cells M3nQ[mN6fG:2b4jpZ4l1gSCjc4PhfS=> MWC3NkBp MoK5R5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gRVU1QSClZXzsd{Bi\nSncjC3NkBpenNiYomgUXRVKGG|c3H5MEBGSzVyPUmuO|Qh|ryP NF;YOZYyQTlzN{WyPC=>
LAC cells NFixR5BEgXSxdH;4bYNqfHliYYPzZZk> NUDtOmJvPzJiaB?= MnLtR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gUGFEKGOnbHzzJIFnfGW{IEeyJIhzeyCkeTDNWHQh[XO|YYmsJGVEPTB;M{KuNFkh|ryP M124TFE6QTF5NUK4
HeLa cells MVLDfZRwfG:6aXPpeJkh[XO|YYm= NUXRT3R6PzJiaB?= M2[zXmN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGhmVGFiY3XscJMh[W[2ZYKgO|IhcHK|IHL5JG1VXCCjc4PhfUwhTUN3ME2xNE4zPiEQvF2= M1;IelE6QTF5NUK4
MDA-MB-231 cells NFvaZVREgXSxdH;4bYNqfHliYYPzZZk> MoTqR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gUWRCNU2ELUKzNUBk\WyuczDveoVz\XiycnXzd4lv\yC3cn;rbY5ie2VicHzhd41qdm:pZX6gZYN1cX[jdH;yMEBKSzVyPUCuNlEh|ryP MUKyNFM3OzF|MB?=
human ACHN cells NV7BeIFtTnWwY4Tpc44h[XO|YYm= M4\ydmFvfGmlYX7j[ZIh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDBR2hPKGOnbHzzJIJ6KFOUQjDhd5NigSxiR1m1NF0zNjFizszN MWSyNFc{OjhzMB?=
PC3 cells MmfySpVv[3Srb36gZZN{[Xl? NGS1VXhCdnSrY3HuZ4VzKGGldHn2bZR6KGGpYXnud5QhcHWvYX6gVGM{KGOnbHzzJIJ6KFOUQjDhd5NigSxiR1m1NF01Njl5IN88US=> MWeyNFc{OjhzMB?=
MDA-MB-231 cells Mmi0SpVv[3Srb36gZZN{[Xl? NYfvNXkxSW62aXPhcoNmeiCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJG1FSS2PQj2yN|Eh[2WubIOgZpkhW1KEIHHzd4F6NCCJSUWwQVAvOTZizszN NGLYemszODd|MkixNC=>
FM3A cells NHK3V5pHfW6ldHnvckBie3OjeR?= MVOyJIRigXN? M{DPb2N6fG:|dHH0bYMh[WO2aY\peJkh[WejaX7zeEBud3W|ZTDGUVNCKGOnbHzzJIFnfGW{IEKg[IF6eyCkeTDjc5VtfGW{IHPveY51cW6pIHHuZYx6e2m|LDDJR|UxRTBwMEC5OEDPxE1? NFqwV2wzOTN|MECxOC=>
HeLa cells NXm0eZVlTnWwY4Tpc44h[XO|YYm= MljpR5l1d3O2YYTpZ{Bi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFjlUIEh[2WubIOgbY4heHKnc3XuZ4Uhd2ZiMkCgeW0hfGi7bXnkbY5mNCCLQ{WwQVgvPSEQvF2= M2fpXVIyOzNyMEG0
LLC cells M4KzUmN6fG:2b4jpZ4l1gSCjc4PhfS=> M4LPd|I1KGh? NXLCZ3FLS3m2b4TvfIlkcXS7IHHnZYlve3RibX;1d4UhVEyFIHPlcIx{KGGodHXyJFI1KGi{czDifUBz\XOjeoXybY4h[XO|YYmsJGlEPTB;MUSuNkDPxE1? MlmxNlE2OzZ2NEi=
LLC cells MUXDfZRwfG:6aXPpeJkh[XO|YYm= NWe0SpdIPzJiaB?= NVLtU5FIS3m2b4TvfIlkcXS7IHHnZYlve3RibX;1d4UhVEyFIHPlcIx{KGGodHXyJFczKGi{czDifUBz\XOjeoXybY4h[XO|YYmsJGlEPTB;MjFOwG0> MX:yNVU{PjR2OB?=
RAW264.7 cells NV\xPIJSS3m2b4TvfIlkcXS7IHHzd4F6 NXvpOpp4PzJiaB?= Mon0R5l1d3SxeHnjbZR6KGGpYXnud5QhdW:3c3WgVmFYOjZ2LkegZ4VtdHNiYX\0[ZIhPzJiaILzJIJ6KHKnc3H6eZJqdiCjc4PhfUwhUUN3ME2zNEDPxE1? NI\iW2ozOTV|NkS0PC=>
A549 cells NH7yc2xEgXSxdH;4bYNqfHliYYPzZZk> NYHWTFB7PzJiaB?= M1r2SWN6fG:2b4jpZ4l1gSCjZ3HpcpN1KGi3bXHuJGE2PDliY3XscJMh[XO|ZYPz[YQh[XNiY3XscEB3cWGkaXzpeJkh[W[2ZYKgO|IhcHK|IHL5JHdUXC16IHHzd4F6NCCLQ{WwQVAvODR5IN88US=> NFvOPXczOjJ2OEi1Oi=>
A2780 cells M4r1[mN6fG:2b4jpZ4l1gSCjc4PhfS=> NWjPTWxmPSCmYYnz NGXKfldEgXSxdH;4bYNqfHliYXfhbY5{fCCqdX3hckBCOjd6MDDj[YxteyCjZoTldkA2KGSjeYOgZpkhVVSWIHHzd4F6NCCLQ{WwQVAvODJ4IN88US=> NFXqS3ozOjd|OE[zOi=>
LMTK cells NH\vW4JEgXSxdH;4bYNqfHliYYPzZZk> NVjTdVJ3PSCmYYnz NYrOXZVwS3m2b4TvfIlkcXS7IHHnZYlve3RidHj5cYllcW6nIHvpcoF{\S2mZX\pZ4lmdnRibX;1d4UhVE2WSzDj[YxteyCjZoTldkA2KGSjeYOgZpkhVVSWIHHzd4F6NCCLQ{WwQVQvPSEQvF2= M2\vNVIzPzN6NkO2
A549 cells NVHGbo1yS3m2b4TvfIlkcXS7IHHzd4F6 NUD5Omp2PzJiaB?= MWfDfZRwfG:6aXPpeJkh[WejaX7zeEBpfW2jbjDBOVQ6KGOnbHzzJIFnfGW{IEeyJIhzeyCkeTDtbYNzd3CuYYTlJJJm[WSncjDt[ZRpd2RuIFnDOVA:OC5yMUK0JO69VQ>? NFr0bnIzOjh2N{CxPS=>
CEM cells MWTGeY5kfGmxbjDhd5NigQ>? NI\FVlc4OiCq Mk\jR5l1d3O2YYTpZ{Bi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFPFUUBk\WyuczDlfJBz\XO|aX7nJIh2dWGwIFXOWFEhfHKjboPwc5J1\XJiYX\0[ZIhPzJiaILzJIJ6KGOnbHygZ492dnSrbnegbY4heHKnc3XuZ4Uhd2ZiTlLNVHItKEmFNUC9NE45KM7:TR?= M37IZlIyQDl{OEK5
Hela cells NWfm[o95TnWwY4Tpc44h[XO|YYm= NFPCWGI4OiCq NXnpTHpZS3m2b4P0ZZRq[yCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJGhmVGFiY3XscJMh[W[2ZYKgO|IhcHK|IHL5JINmdGxiY3;1cpRqdmduIFnDOVA:OC5yNTFOwG0> MkXqNlE5QTJ6Mkm=
CEM/0 cells MkfsSpVv[3Srb36gZZN{[Xl? M4n0cFczKGh? M3GxUWN6fG:|dHH0bYMh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDDSW0wOCClZXzsd{Bi\nSncjC3NkBpenNiYomgZ4VtdCClb4XueIlv\yxiSVO1NF0xNjB{MjFOwG0> NW\0N5ZEOjF6OUK4Nlk>
L1210/0 cells NHqxfpZHfW6ldHnvckBie3OjeR?= NEPyZXU1QCCq MlXRR5l1d3O2YYTpZ{Bi[3Srdnn0fUBi\2GrboP0JI1wfXOnIFyxNlExNzBiY3XscJMh[W[2ZYKgOFghcHK|IHL5JINmdGxiY3;1cpRqdmduIFnDOVA:OC5yMEC5JO69VQ>? NXrtVY1kOjF6OUK4Nlk>
MCF7 cells Mn3QR5l1d3SxeHnjbZR6KGG|c3H5 M2HHTlczKGh? MnnnR5l1d3SxeHnjbZR6KGGpYXnud5QhcHWvYX6gUWNHPyClZXzsd{Bi\nSncjC3NkBpenNiYomgV3JDKGG|c3H5MEBKSzVyPUGyMlE6KM7:TR?= MnrtNlM5Pjd4MEO=
HeLa cells NFLBOFZEgXSxdH;4bYNqfHliYYPzZZk> NGn2bIc4OiCq NUmyNWFHS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hUGWOYTDj[YxteyCjZoTldkA4OiCqcoOgZpkhW1KEIHHzd4F6NCCLQ{WwQVYvPSEQvF2= MWGyN|g3PzZyMx?=
HL60 cells MUPQdo9tcW[ncnH0bY9vKGG|c3H5 MkC3O|IhcA>? M{TufGFvfGmycn;sbYZmemG2aY\lJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iSFy2NEBk\WyuczDhd5Nme3OnZDDhd{Boem:5dHigbY5pcWKrdHnvckBi\nSncjC3NkBpenNiYomgUXRVKGG|c3H5MEBKSzVyPUCuNlQh|ryP MYSyOVY1PDZ5NB?=
SW707 cells NXfJVG42WHKxbHnm[ZJifGmxbjDhd5NigQ>? M{K4WVczKGh? NVvxZlF3SW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDTW|cxPyClZXzsd{Bie3Onc4Pl[EBieyCpcn;3eIghcW6qaXLpeIlwdiCjZoTldkA4OiCqcoOgZpkhW1KEIH3leIhw\CxiSVO1NF0zOy56NjFOwG0> NWjtUZprOjV4NES2O|Q>
LoVo cells MkDlVJJwdGmoZYLheIlwdiCjc4PhfS=> MnLRO|IhcA>? NYfIclhuSW62aYDyc4xq\mW{YYTpeoUh[WO2aY\peJkh[WejaX7zeEBpfW2jbjDMc3ZwKGOnbHzzJIF{e2W|c3XkJIF{KGe{b4f0bEBqdmirYnn0bY9vKGGodHXyJFczKGi{czDifUBUWkJibXX0bI9lNCCLQ{WwQVE6NjB5IN88US=> NV;vXYh[OjV4NES2O|Q>
BALB/3T3 cell M2HGVnBzd2yrZnXyZZRqd25iYYPzZZk> M4Dne|czKGh? MXLBcpRqeHKxbHnm[ZJifGm4ZTDhZ5Rqfmm2eTDh[4FqdnO2IH3veZNmKEKDTFKvN3Q{KGOnbHzzJIF{e2W|c3XkJIF{KGe{b4f0bEBqdmirYnn0bY9vKGGodHXyJFczKGi{czDifUBUWkJibXX0bI9lNCCLQ{WwQVI{NjlizszN MoTMNlU3PDR4N{S=
HFF cells NFXVd4lHfW6ldHnvckBie3OjeR?= MoSzO|IhcA>? MWHBcpRqeGG{YYPpeIlkKGGldHn2bZR6KGGpYXnud5QhXG:6b4DsZZNu[SCpb37kbYkhSVSFQzC1NFg{QSCrbn\lZ5Rm\CCrbjDISmYh[2WubIOgZYZ1\XJiN{KgbJJ{KGK7IHLleIEu\2GuYXP0c5Nq\GG|ZTDy[ZBwenSncjDn[Y5mKGG|c3H5MEBGSzVyPUCuPVEh|ryP M1v6TVE4Pjl6NkG4
CCRFCEM cells MoHiSpVv[3Srb36gZZN{[Xl? MoP6R5l1d3O2YYTpZ{Bi[3Srdnn0fUBi\2GrboP0JIh2dWGwIFPDVmZETU1iY3XscJMh[nliTWTUJIF{e2G7LDDJR|UxRTBwMkmg{txO M3nPWVE4QDB2MkOx
RXF393 cells NWezOG5iTnWwY4Tpc44h[XO|YYm= MkXNOFghcA>? NXTvVnltSW62aXPhcoNmeiCjY4Tpeol1gSCjZ3HpcpN1KGi3bXHuJHJZTjN7MzDj[YxteyCjZoTldkA1QCCqcoOgZpkhe3WuZn;ybI9l[W2rbnWgRkBie3OjeTygS2k2OD1|Lkm4NVA4KM7:TR?= M1\Hc|E6PzR2OEW4
HL-60(TB) cells M4PoS2Z2dmO2aX;uJIF{e2G7 NVTpTpNtPDhiaB?= MWTBcpRq[2GwY3XyJIFkfGm4aYT5JIFo[Wmwc4SgbJVu[W5iSFytOlApXEJrIHPlcIx{KGGodHXyJFQ5KGi{czDifUB{fWyob4Loc4RidWmwZTDCJIF{e2G7LDDHTVUxRTBwMUm5OVMh|ryP M1HRSlE6PzR2OEW4
L1210 cells MoHySpVv[3Srb36gZZN{[Xl? M4nEVlE2KG2rboO= NEnRWYxKdmirYnn0bY9vKG:oIITofY1q\HmuYYTlJJN6dnSqYYPlJIlvKG2xdYPlJGwyOjFyIHPlcIx{KGG|c3Xzd4VlKGG|IHnubIljcXSrb36gc4YhfHKrdHn1cUBz\WynYYPlJIZzd21iW{WtN2he\GWxeIn1dollcW6nIHHmeIVzKHC{ZXnuZ5Vj[XSrb36g[o9zKDF3IH3pcpMh[nlibHnxeYllKHOlaX70bYxt[XSrb36gZ492dnSrbnesJGlEPTB;MD6wNFA3KM7:TR?= MmrjNlE{OzByMUS=
Colo-357 cells NHPNZVVHfW6ldHnvckBie3OjeR?= MnPTNVAxKM7:TR?= NX;jbXhqOTVibXnudy=> MlzJRYN1cX[rdImgZZQhVVKSNTDpckBpfW2jbjDDc4xwNTN3NzDj[YxteyCjc4Pld5Nm\CCjczC1MWZlXU2SIHHjZ5VufWyjdHnvckBifCBzMECgeW0h[W[2ZYKgNVUhdWmwcx?= NXzhWXZROjB7M{CxNlM>
KB cells MXvDfZRwfG:6aXPpeJkh[XO|YYm= MlvhO|IhcA>? NYqzbIlMS3m2b4TvfIlkcXS7IHHnZYlve3RiaIXtZY4hU0JiY3XscJMh[W[2ZYKgO|IhcHK|IHL5JHNTSiCjc4PhfUwhUUN3ME24MlY6KM7:TR?= NILPSXozOzh4N{[wNy=>

... Click to View More Cell Line Experimental Data

Protocol

Solubility (25°C)

In vitro DMSO 49 mg/mL (199.03 mM)
Water 49 mg/mL (199.03 mM)
Ethanol 10 mg/mL (40.61 mM)

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 246.19
Formula

C9H11FN2O5

CAS No. 50-91-9
Storage powder
Synonyms Deoxyfluorouridine, FDUR, NSC 27640

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Clinical Trial Information

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT02529774 Not yet recruiting Resected Liver Metastases From Colorectal Cancer Ye Xu|Fudan University September 2015 Phase 2|Phase 3
NCT01938729 Active, not recruiting Intrahepatic Cholangiocarcinoma|Peripheral Cholangiocarcinoma|Cholangiolar Carcinoma|Cholangiocellular Carcinoma) (ICC) Memorial Sloan Kettering Cancer Center|Ohio State University|University of Texas Southwestern Medical Center|Washington University School of Medicine September 2013 Phase 1
NCT01862315 Recruiting Intrahepatic Cholangiocarcinoma|Peripheral Cholangiocarcinoma|Cholangiolar Carcinoma|Cholangiocellular Carcinoma Memorial Sloan Kettering Cancer Center|Ohio State University|University of Texas|Washington University School of Medicine May 2013 Phase 2
NCT01749397 Recruiting Stage IV Fallopian Tube Cancer|Stage IV Ovarian Cancer|Stage IV Primary Peritoneal Cancer National Cancer Institute (NCI) December 2012 Phase 1
NCT01692704 Completed Cholangiocellular Carcinoma University of Zurich April 2012 Phase 1|Phase 2
NCT01525069 Recruiting Cholangiocarcinoma|Liver Neoplasms Washington University School of Medicine April 2012 Phase 1

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

DNA/RNA Synthesis Signaling Pathway Map

Related DNA/RNA Synthesis Products

Tags: buy Floxuridine | Floxuridine supplier | purchase Floxuridine | Floxuridine cost | Floxuridine manufacturer | order Floxuridine | Floxuridine distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID